Symptoms

Pain may be the most prevalent symptom of Long COVID -- study

Pain Identified as Dominant Symptom in Long COVID

New research shows that pain—a common complaint of individuals experiencing long-term symptoms from the COVID-19 virus—may actually be the most prevalent and severe symptom reported in those with long COVID.

..

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Air pollution may boost risk of longer-term long-COVID symptoms --study

Exposure to small- or fine-particle air pollution may predispose COVID-19 survivors to a longer duration of persistent symptoms by increasing the severity of the infection, among other contributing factors, finds a study led by the Barcelona Institute for Global Health (ISGlobal).

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Men more likely than women to develop COVID-19 pneumonia --study

A study of sex-based differences in the risk of COVID-19 pneumonia finds that men were more likely to develop the complication than women (12.0% vs 7.0%) during the declared pandemic period and the early months of the endemic phase of the disease in Mexico.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Reduced risk of long COVID after vaccination shown in analysis of 25 studies

A new meta-analysis of studies involving more than 14 million people published in the Journal of Infection shows that COVID-19 vaccination is associated with a lower risk of developing long COVID, with two doses reducing the odds by 24% and one dose reducing the odds by 15%.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Long COVID: Lungs might hold clues to long COVID brain fog --study

...

Reduced gas exchange in the lungs -- oxygen coming in, carbon dioxide going out -- appears to be associated with brain fog in long COVID, researchers will report in Chicago at next week's annual meeting of the Radiological Society of North America.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

No unexpected COVID vaccine safety concerns in young children--study

A new research letter published yesterday in JAMA Network Open shows no new safety concerns or reactogenicity signals among babies and toddlers who received their first COVID-19 vaccines by the age of 2.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Symptoms
howdy folks
Page loaded in 0.603 seconds.